Day: March 27, 2026

Linamar Corporation to Acquire Winning BLW’s Remscheid and Penzberg Facilities, Expanding Its Forging and Gear Manufacturing

Written by Customer Service on March 27, 2026. Posted in Mergers And Acquisitions.

GUELPH, Ontario, March 27, 2026 (GLOBE NEWSWIRE) — Linamar Corporation (TSX:LNR) is pleased to announce that it has entered into a definitive agreement to acquire the Remscheid and Penzberg facilities of Winning BLW. This strategic transaction further expands Linamar’s product portfolio and manufacturing capabilities, adding approximately $200 million CAD in annualized revenue and further strengthening the company’s global footprint. The Remscheid facility is a leader in mass production of high-performance precision bevel and intermediate gears for the light vehicle market, while the Penzberg facility specializes in helical gears and high-precision components serving the commercial and off-highway sectors. Through these acquisitions, Linamar significantly expands its forging expertise to include warm forging, expanding its already...

NN Announces Acquisition to Further Growth in Electric Grid and Data Center

Written by Customer Service on March 27, 2026. Posted in Mergers And Acquisitions.

CHARLOTTE, N.C., March 27, 2026 (GLOBE NEWSWIRE) — NN, Inc. (“NN” or the “Company”) (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies with six sigma quality today announced that it has acquired the large-scale automated plating operations from a leading global provider of electrical infrastructure solutions. This seller is an existing customer which is moving from in-house manufacturing to outsourced operations with this decision. The equipment acquisition will enable NN to significantly expand its processing capabilities in silver-plated busbars and terminals among other capabilities, which are ideal electrical components for electric grid and data center equipment. This further enables NN to broaden its market aperture on growth in this area, its second...

BTCS Reports 305% Year-Over-Year Revenue Growth to Record $16.5 Million for Full Year 2025

Written by Customer Service on March 27, 2026. Posted in Earnings Releases And Operating Results.

Revenue growth driven by expanding Builder+ block-building activity, with Imperium delivering $1.3 million in revenue following its Q3’25 launch WAYNE, Pa., March 27, 2026 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), short for Blockchain Technology Consensus Solutions, a company focused on blockchain infrastructure and decentralized finance operations, today announced its financial results for the year ended December 31, 2025 (“FY 2025”). The Company also released an updated investor presentation available at www.btcs.com/investors/. “2025 was a transformative year for BTCS as we scaled our Ethereum-first operating model and delivered record revenue,” said Charles Allen, Chief Executive Officer of BTCS. “Revenue grew over 300%, driven by the expansion of Builder+, our block-building business, and the successful...

LM Funding America, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Written by Customer Service on March 27, 2026. Posted in Earnings Releases And Operating Results.

– Fourth quarter revenue of $2.4 million, up 8.7% sequentially and 19.2% year-over-year TAMPA, Fla., March 27, 2026 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today reported financial results for the three and twelve months ended December 31, 2025. Fourth Quarter 2025 Financial HighlightsTotal revenue for the fourth quarter ended December 31, 2025 was $2.4 million dollars, up 8.7% sequentially from Q3 2025 and 19.2% for the quarter year-over-year. The sequential increase reflects higher Bitcoin production but partial offset by a lower average Bitcoin price. The Company mined 22.0 Bitcoin during the fourth quarter 2025 at an average price of approximately $99,700, compared to 17.6 Bitcoin in Q3 2025 at an average Bitcoin value of approximately...

Super League Reports Fourth Quarter and Full Year 2025 Financial Results, Completes Business Transformation and Advances Path to Profitability

Written by Customer Service on March 27, 2026. Posted in Earnings Releases And Operating Results.

~ Q4 2025 Delivers Strongest Revenue Quarter of the Year ~ ~ Debt-Free Balance Sheet and $14M in Year-End Cash Enable Focus on Execution ~ ~ Diversified Revenue and Shift to Scalable Offerings Support Path to Profitable Future ~ SANTA MONICA, March 27, 2026 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLE) (the “Company”), an audience intelligence and media activation company that generates revenue by executing interactive advertising and immersive content programs for brands seeking to reach and influence people who play video games, today released fourth quarter and full year 2025 financial results. Super League Chief Executive Officer, Matt Edelman Commented: “Super League is a fundamentally different company than it was a year ago. We have a stronger foundation and a clearer path to scale, positioned to help brands reach and influence...

Norwegian Cruise Line Holdings Enters into Employment and Equity Award Agreements with President and CEO

Written by Customer Service on March 27, 2026. Posted in Public Companies.

MIAMI, March 27, 2026 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH), a leading global cruise company operating Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises (“NCLH” or the “Company”), announced that it has entered into an employment agreement and restricted share unit award agreement with John W. Chidsey, its President and Chief Executive Officer on March 26, 2026, in connection with his appointment. Mr. Chidsey was appointed as President and Chief Executive Officer on February 12, 2026. He has extensive experience leading large global consumer-facing businesses, including companies with franchised and other yield-driven, asset-intensive operating models. Over the course of his career, he has served in numerous executive leadership roles at pivotal moments, focusing on improving operational...

Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone

Written by Customer Service on March 27, 2026. Posted in Public Companies.

TORONTO, March 27, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that Texas Prostate, led by Dr. James Cochran, has achieved its 100th TULSA Procedure™ performed in Dallas Medical Center’s state-of-the-art MRI suite. “Having performed hundreds of focal HIFU procedures for prostate cancer patients, we switched to primarily offering the TULSA Procedure because its unique MRI-guidance and thermography allow us to treat a much broader range of prostate diseases, sizes, severities, and aggressions, with an improved safety profile. With TULSA, by planning and delivering therapy under continuous, in‑bore...

Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

Written by Customer Service on March 27, 2026. Posted in Public Companies.

Vancouver, Canada, March 27, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the filing of a patent application in India covering innovative next-generation psychedelic-based compounds for the treatment of mental health disorders and addiction. The patent application, filed with the Indian Patent Office, forms part of the Company’s expanding global intellectual property portfolio and builds upon its exclusive worldwide licensing agreement with Yissum Research Development Company of the Hebrew University of Jerusalem. It protects novel new compounds designed...

Tallinna Vesi’s Supervisory Council approved the annual report for 2025 and the dividend proposal

Written by Customer Service on March 27, 2026. Posted in Dividend Reports And Estimates.

The Supervisory Council of AS Tallinna Vesi has approved the audited annual report for 2025 and will submit it to the Annual General Meeting of Shareholders for approval. The financial results have not changed from the unaudited results published on 6 February 2026. The audited annual report for 2025 is attached to this announcement and can also be found on Tallinna Vesi’s website. Dividend proposal Tallinna Vesi has formulated a dividend policy based on the price regulation principles for water services, with the aim of providing investors with greater clarity regarding the future. The company’s dividend policy aims to distribute 50–80% of the company’s annual profits to shareholders in the form of dividends. The amount to be paid in dividends is determined annually, considering the company’s earnings, investment...

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

Written by Customer Service on March 27, 2026. Posted in Earnings Releases And Operating Results.

– Total revenues from sales and research collaborations were $0.5 million for fourth quarter and $2.0 million for full year – – Purchase commitment received for a minimum of $1.475 million for a clinical evaluation and outreach program in the Kingdom of Saudi Arabia – – Submitted of a Marketing Authorization Application with the Israel Ministry of Health – – U.S. Department of Defense authorized funding for procurement of bioengineered blood vessels – – Major milestone upcoming: Top-line interim result from V012 Phase 3 study in hemodialysis access – – Conference call today at 8:00 am ET – DURHAM, N.C., March 27, 2026 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered...

Day: March 27, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals